Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial
In conclusion, low-dose intracoronary urokinase during primary PCI is associated with a more favourable 5-year outcome of patients with STEMI.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Angioplasty | Cardiology | Coronary Angioplasty | Heart | Heart Attack | Heart Failure | Hematology | Percutaneous Coronary Intervention | Perfusion | Thrombosis